Stephen Doster

  • Home

    Home

    Mission The mission of the VU Biomolecular Multimodal Imaging Center (BIOMIC) isto build a platform of integrated technologies for imaging and molecular analysis that enables the construction of comprehensive 3-dimensional (3-D) molecular atlases of human tissues. The technologies that we are bringing together in BIOMIC have been specifically selected to… Read More

    Apr. 26, 2019

  • Vanderbilt University

    A new framework for genome-wide association studies

    A multi-institutional team of researchers, led by Basic Sciences faculty member Bingshan Li (Molecular Physiology & Biophysics), has developed a new framework that can help researchers learn more from genome-wide association studies (GWAS) than previously was possible. Their work was published in Nature Neuroscience. Read More

    Apr. 25, 2019

  • Vanderbilt University

    Yohn named Postdoc of the Year at annual symposium

    Apr. 22, 2019, 1:59 PM By Irene McKirgan Samantha Yohn, 2019 Vanderbilt Postdoc of the Year. (Anne Rayner/Vanderbilt) Postdoctoral scholar Samantha Yohn has been named Postdoc of the Year by the Office of Postdoctoral Affairs for her exceptional research scholarship. Since 2008, the… Read More

    Apr. 24, 2019

  • Vanderbilt University

    Sappington named Mentor of the Year

    Graduate School Dean Mark Wallace (left) and Rebecca Sappington, 2019 Vanderbilt Mentor of the Year. (Anne Rayner/Vanderbilt) Rebecca Sappington, associate professor of ophthalmology and visual sciences, was honored as Mentor of the Year by the Office of Postdoctoral Affairs. This award recognizes faculty… Read More

    Apr. 24, 2019

  • Vanderbilt University

    Researchers find high-risk genes for schizophrenia

    Researchers who helped find high-risk genes for schizophrenia included, from left, Quan Wang, PhD, Bingshan Li, PhD, Nancy Cox, PhD, Rui Chen, PhD, Xue Zhong, PhD, Qiang Wei, PhD, and James Sutcliffe, PhD. (photo by John Russell) by Bill Snyder Using a unique computational framework they developed, a team of… Read More

    Apr. 18, 2019

  • Vanderbilt University

    The arrestin-GPCR connection

    Apr. 11, 2019, 12:00 PM by Sanjay Mishra G-protein coupled receptors (GPCRs) are the “inbox” of environmental messages in mammalian cells. Because of their central role in signaling pathways, mutations resulting in abnormal GPCR functions cause a wide variety of diseases. Therefore, GPCRs are the most intensively studied drug targets. After… Read More

    Apr. 18, 2019

  • Vanderbilt University

    Former VU Teacher and Nobel Laureate Paul Greengard Dies

    Neurobiologist Paul Greengard Dies The Nobel laureate revolutionized our understanding of how brain cells communicate. Apr 15, 2019 ASHLEY YEAGER, The Scientist (the-scientist.com) Nobel laureate Paul Greengard, a neurobiologist at Rockefeller University, died Saturday (April 13). He was 93. Greengard is best known for his work showing that the… Read More

    Apr. 15, 2019

  • Vanderbilt University

    Study reframes approach to targeted therapy resistance

    Apr. 11, 2019, 9:02 AM From left, Benjamin Brown, Christine Lovly, MD, PhD, Yun-Kai Zhang, PhD, Jens Meiler, PhD, and colleagues are exploring new ways to understand resistance to targeted cancer therapy drugs. (photo by Anne Rayner) by Tom Wilemon When a tumor mutates and develops resistance to a targeted… Read More

    Apr. 11, 2019

  • Vanderbilt University

    Discovery aids search for cancer biomarkers

    Discovery aids search for cancer biomarkers Apr. 11, 2019, 10:39 AM Research by Robert Coffey, MD, left, Dennis Jeppesen, PhD, and colleagues has revealed a new way cells shed DNA into the bloodstream. (photo by Steve Green) by Bill Snyder A report by researchers at Vanderbilt University Medical Center has… Read More

    Apr. 11, 2019

  • Vanderbilt University

    Cancer’s SOS

    Mar. 28, 2019, 11:30 AM by Sanjay Mishra RAS proteins regulate growth, survival and proliferation of cells in their active state. However, the uncontrolled activation of RAS causes approximately a third of all tumors and helps cancerous cells evade anti-cancer drugs. Thus RAS is an important target for effective anti-cancer treatments. Read More

    Apr. 4, 2019